Apollomics (APLM) Debt Ratio (2023 - 2025)
Apollomics (APLM) posted quarterly Debt Ratio of 0.45 for Q4 2025, up 24.39% on a QoQ basis from 0.36 in Q2 2025.
Apollomics (APLM) Debt Ratio (2023 - 2025) Analysis & Trends
Apollomics (APLM) has reported Debt Ratio for 3 consecutive years, with 0.45 the latest figure, recorded in Q4 2025.
- Quarterly Debt Ratio changed N/A year-over-year to 0.45 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.45 (changed N/A YoY) and the FY2025 annual result came in at 0.45, changed N/A from the prior year.
- Debt Ratio advanced to 0.45 in Q4 2025 per APLM's latest filing, from 0.36 in the prior quarter.
- Over the last five years, Debt Ratio for APLM reached as high as 0.45 in Q4 2025 and fell as low as 0.1 in Q4 2023.
- A 3-year average of 0.27 and a median of 0.26 in 2025 frame the typical range for Debt Ratio.
- The largest YoY upside for Debt Ratio was 114.34% in 2025 against a maximum downside of 114.34% in 2025.
- Year by year, Debt Ratio stood at 0.1 in 2023, then soared by 64.12% to 0.17 in 2024, then soared by 166.62% to 0.45 in 2025.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.45, 0.36, and 0.17 for Q4 2025, Q2 2025, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | 0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.45 |
| Jun 30, 2025 | 0.36 |
| Jun 30, 2024 | 0.17 |
| Dec 31, 2023 | 0.10 |